BE786200A - Traitement par inhalation de maladies bronchiques - Google Patents

Traitement par inhalation de maladies bronchiques

Info

Publication number
BE786200A
BE786200A BE786200DA BE786200A BE 786200 A BE786200 A BE 786200A BE 786200D A BE786200D A BE 786200DA BE 786200 A BE786200 A BE 786200A
Authority
BE
Belgium
Prior art keywords
inhalation treatment
bronchial diseases
bronchial
diseases
inhalation
Prior art date
Application number
Other languages
English (en)
Original Assignee
Boehringer Sohn Ingelheim
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Publication date
Publication of BE786200A publication Critical patent/BE786200A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BE786200D 1971-07-13 Traitement par inhalation de maladies bronchiques BE786200A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2134899A DE2134899C3 (de) 1971-07-13 1971-07-13 Verwendung von N-Äthyl-norscopolaminmethobromid

Publications (1)

Publication Number Publication Date
BE786200A true BE786200A (fr) 1973-01-12

Family

ID=5813500

Family Applications (1)

Application Number Title Priority Date Filing Date
BE786200D BE786200A (fr) 1971-07-13 Traitement par inhalation de maladies bronchiques

Country Status (13)

Country Link
US (1) US4016279A (fr)
AU (1) AU470025B2 (fr)
BE (1) BE786200A (fr)
CA (1) CA988418A (fr)
DE (1) DE2134899C3 (fr)
FR (1) FR2145693B1 (fr)
GB (1) GB1392094A (fr)
HK (1) HK49679A (fr)
IE (1) IE36952B1 (fr)
IL (1) IL39889A (fr)
IT (1) IT1116880B (fr)
NL (1) NL175493C (fr)
ZA (1) ZA724724B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4183912A (en) * 1978-01-16 1980-01-15 American Home Products Corporation Inhalation therapy for relieving bronchial spasm using quaternary salts of promethazine
IT1164227B (it) * 1983-05-13 1987-04-08 Angeli Inst Spa Composizione farmaceutica atta alla somministrazione nasale di sali quaternari d'ammonio ed attivita' anticolinergica
US4581225A (en) * 1984-04-25 1986-04-08 Eli Lilly And Company Sustained release intranasal formulation and method of use thereof
RU2684761C1 (ru) * 2018-02-20 2019-04-12 Федеральное государственное бюджетное образовательное учреждение высшего образования "Сибирский государственный медицинский университет" Министерства здравоохранения Российской Федерации (ФГБОУ ВО СибГМУ Минздрава России) Способ профилактики респираторных осложнений у пациентов после хирургического лечения рака легкого

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2753288A (en) * 1953-01-12 1956-07-03 Upjohn Co Scopolamine lower-alkyl halide therapeutic composition
US3169095A (en) * 1962-10-30 1965-02-09 Rexall Drug Chemical Self-propelling powder-dispensing compositions
DE1670048C3 (de) * 1966-01-26 1980-09-04 C.H. Boehringer Sohn, 6507 Ingelheim Neue Norscopolaminderivate

Also Published As

Publication number Publication date
DE2134899B2 (de) 1980-07-10
HK49679A (en) 1979-07-27
IT1116880B (it) 1986-02-10
ZA724724B (en) 1974-03-27
AU470025B2 (en) 1976-03-04
NL7209675A (fr) 1973-01-16
IL39889A (en) 1976-05-31
NL175493C (nl) 1984-11-16
IE36952B1 (en) 1977-03-30
AU4449872A (en) 1974-01-17
NL175493B (nl) 1984-06-18
FR2145693B1 (fr) 1976-03-05
IE36952L (en) 1973-01-13
IT7949433A0 (it) 1979-06-15
DE2134899A1 (de) 1973-02-01
IL39889A0 (en) 1972-09-28
GB1392094A (en) 1975-04-23
DE2134899C3 (de) 1981-04-02
CA988418A (en) 1976-05-04
FR2145693A1 (fr) 1973-02-23
US4016279A (en) 1977-04-05

Similar Documents

Publication Publication Date Title
FI54916B (fi) Foerfarande foer framstaellning av terapeutiskt verksamma n-substituerade 2-pyrrolidoner
SE384529B (sv) Apparat for behandling av djurhudar eller liknande
ZA72423B (en) Improvements in or relating to the treatment of diseases of the skin or mucosa
BE791735A (fr) Element de traitement intra-uterin
BE871009Q (fr) Traitement des affections fongiques
BE761596A (fr) Traitement de latex
FI54100B (fi) Foerfarande foer framstaellning av terapeutiskt vaerdefulla tricykliska foereningar
IL40600A (en) Purification of human blood
BE785661A (fr) Procede de traitement de maladies par administration du coenzyme a et de l'adenosine triphosphate
BE786200A (fr) Traitement par inhalation de maladies bronchiques
BE777292A (fr) Appareil de traitement
BE821888A (fr) Traitement de dispersions de gouttelettes
FI55988C (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara o-acylfenoletanolaminer
BE841614A (fr) Traitement des animaux
BE790811A (fr) Traitement du titane
SE7614232L (sv) Behandling av spolvetska
BE782422A (fr) Traitement de gaz
BE788120A (fr) Traitement des proteines du petit-lait
BE786606A (fr) Procede de traitement de la gonorrhee
BE791982A (fr) Traitement de suspensions
BE783061A (fr) Traitement enzymatique de legumineuses
SU460868A1 (ru) Способ косвенной оценки эффективности антибактериального лечени неспецифических заболеваний бронхиального дерева и легких
BE753238A (fr) Prophylaxie et traitement des maladies cardiaques
BE790142A (fr) Traitement ameliorant des polypentenameres
BE795269A (fr) Traitement d'affections cardiaques

Legal Events

Date Code Title Description
RE20 Patent expired

Owner name: C.H. BOEHRINGER SOHN

Effective date: 19920712